FDA Import Refusal 1FX-4500417-4/30003/1 — WEDERM PRIVATE LIMITED
The FDA refused shipment 1FX-4500417-4/30003/1 from WEDERM PRIVATE LIMITED (India) on September 24, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- September 24, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75